Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for BioHarvest Sciences Inc. (BHST : NSDQ)

• Company Description    BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada. Number of Employees: 87

• Price / Volume Information    Yesterday's Closing Price: $5.19 Daily Weekly Monthly 20 Day Moving Average: 59,023 shares Shares Outstanding: 16.42 (millions) Market Capitalization: $85.25 (millions) Beta: 1.12 52 Week High: $12.80 52 Week Low: $4.72 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -17.36% -17.22% 12 Week -56.86% -57.55% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1140 - 625 HOWE STREET - VANCOUVER,BC V6C 2T6 CAN ph: 646-863-2177 fax: - bhst@mzgroup.us https://bioharvest.com

• General Corporate Information    Officers Ilan Sobel - Chief Executive Officer Zaki Rakib - Chairman of the Board Ilana Belzer - Chief Operating Officer Alan Rootenberg - Chief Financial Officer Michal Sapir - Vice President Peer Information BioHarvest Sciences Inc. (CORR.) BioHarvest Sciences Inc. (RSPI) BioHarvest Sciences Inc. (CGXP) BioHarvest Sciences Inc. (BGEN) BioHarvest Sciences Inc. (GTBP) BioHarvest Sciences Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 09076J207 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/30/26 Share - Related Items Shares Outstanding: 16.42 Most Recent Split Date: 6.00 (0.03:1) Beta: 1.12 Market Capitalization: $85.25 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.08 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.00 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/30/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 11.02 Price/Cash Flow: - Price / Sales: 2.61 EPS Growth vs. Year Ago Period: 12.50% vs. Previous Quarter: 6.67% Sales Growth vs. Year Ago Period: 38.66% vs. Previous Quarter: 6.48% ROE 12/31/25 - - 09/30/25 - -1,041.86 06/30/25 - -11,357.84 ROA 12/31/25 - - 09/30/25 - -36.06 06/30/25 - -39.94 Current Ratio 12/31/25 - - 09/30/25 - 1.35 06/30/25 - 0.60 Quick Ratio 12/31/25 - - 09/30/25 - 1.02 06/30/25 - 0.36 Operating Margin 12/31/25 - - 09/30/25 - -31.57 06/30/25 - -34.80 Net Margin 12/31/25 - - 09/30/25 - -36.33 06/30/25 - -39.95 Pre-Tax Margin 12/31/25 - - 09/30/25 - -35.88 06/30/25 - -39.67 Book Value 12/31/25 - - 09/30/25 - 0.47 06/30/25 - -0.26 Inventory Turnover 12/31/25 - - 09/30/25 - 3.29 06/30/25 - 3.38 Debt-to-Equity 12/31/25 - - 09/30/25 - 0.30 06/30/25 - - Debt-to-Capital 12/31/25 - - 09/30/25 - 23.25 06/30/25 - -

Powered by Zacks Investment Research ©